Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma

Journal of Clinical Microbiology

Volumn 46, Issue 1, 2008, Pages 274-280

  Guo, Ming ^a   Gong, Yun ^a   Deavers, Michael ^a   Silva, Elvio G ^a   Yee, Jee Jan ^b   Cogdell, David E ^a   Luthra, Rajyalashmi ^a   Lin, E ^a   Hung, Cheng Lai ^c   Zhang, Wei ^a   Sneige, Nour ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA DETERMINATION; EPISOME; EVALUATION; FALSE NEGATIVE RESULT; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADOLESCENT; ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; FEMALE; GENOTYPE; HUMANS; IN SITU HYBRIDIZATION; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 38149072925     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01299-07     Document Type: Article

References (39)

1. Acladious, N. N., C. Sutton, D. Mandal, R. Hopkins, M. Zaklama, and H. Kitchener. 2002. Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN). Int. J. Cancer 98:435-439.
2. Andersson, S., H. Safari, M. Mints, I. Lewensohn-Fuchs, U. Gyllensten, and B. Johansson. 2005. Type distribution, viral load, and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN). Br. J. Cancer 92:2195-2200.
3. Baay, M. F., W. G. Quint, J. Koudstaal, H. Hollema, J. M. Duk, M. P. Burger, E. Stolz, and P. Herbrink. 1996. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J. Clin. Microbiol. 34:745-747.
4. Bauer, H. M., Y. Ting, C. E. Greer, J. C. Chambers, C. J. Tashiro, J. Chi mera, A. Reingold, and M. M. Manos. 1991. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 265:472-477.
5. Biedermann, K., N. Dandachi, M. Trattner, G. Vogl, H. Doppelmayr, E. More, A. Staudach, O. Dietze, and C. Hauser-Kronberger. 2004. Comparison of real-time PCR signal-amplified in situ hybridization and conventional PCR for detection and quantification of human papillomavirus in archival cervical cancer tissue. J. Clin. Microbiol. 42:3758-3765.
6. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, K. V. Shah, et al. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:796-802.
7. Chan, P. K., T. H. Cheung, A. O. Tam, K. W. Lo, S. F. Yim, M. M. Yu, K. F. To, Y. F. Wong, J. L. Cheung, D. P. Chan, M. Hui, and M. Ip. 2006. Biases in human papillomavirus genotype prevalence assessment associated with commonly used consensus primers. Int. J. Cancer 118:243-245.
8. Cheung, A. L., A. H. Graf, C. Hauser-Kronberger, O. Dietze, R. R. Tubbs, and G. W. Hacker. 1999. Detection of human papillomavirus in cervical carcinoma: comparison of peroxidase, Nanogold, and catalyzed reporter deposition (CARD)-Nanogold in situ hybridization. Mod. Pathol. 12:689-696.
9. Cooper, K., C. S. Herrington, J. E. Stickland, M. F. Evans, and J. O. McGee. 1991. Episomal and integrated human papillomavirus in cervical neoplasia shown by non-isotopic in situ hybridization. J. Clin. Pathol. 44:990-996.
10. Dabic, M. M., L. Hlupic, D. Babic, S. Jukic, and S. Seiwerth. 2004. Comparison of polymerase chain reaction and catalyzed signal amplification in situ hybridization methods for human papillomavirus detection in paraffin-embedded cervical preneoplastic and neoplastic lesions. Arch. Med. Res. 35:511-516.
11. Evans, M. F., S. L. Mount, B. G. Beatty, and K. Cooper. 2002. Biotinyltyramide-based in situ hybridization signal patterns distinguish human papillomavirus type and grade of cervical intraepithelial neoplasia. Mod. Pathol. 15:1339-1347.
12. Flores-Munguia, R., E. Siegel, W. T. Klimecki, and A. R. Giuliano. 2004. Performance assessment of eight high-throughput PCR assays for viral load quantitation of oncogenic HPV types. J. Mol. Diagn. 6:115-124.
13. Fontaine, J., C. Hankins, M. H. Mayrand, J. Lefevre, D. Money, S. Gagnon, A. Rachlis, K. Pourreaux, A. Ferenczy, and F. Coutlee. 2005. High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV. AIDS 19:785-794.
14. Fujii, T., N. Masumoto, M. Saito, N. Hirao, S. Niimi, M. Mukai, A. Ono, S. Hayashi, K. Kubushiro, E. Sakai, K. Tsukazaki, and S. Nozawa. 2005. Comparison between in situ hybridization and real-time PCR technique as a means of detecting the integrated form of human papillomavirus 16 in cervical neoplasia. Diagn. Mol. Pathol. 14:103-108.
15. Gravitt, P. E., C. L. Peyton, T. Q. Alessi, C. M. Wheeler, F. Coutlee, A. Hildesheim, M. H. Schiffman, D. R. Scott, and R. J. Apple. 2000. Improved amplification of genital human papillomaviruses. J. Clin. Microbiol. 38:357-361.
16. Guo, M., N. Sneige, E. G. Silva, et al. 2007. Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma. Mod. Pathol. 20:256-266.
17. Ho, C. M., T. Y. Chien, S. H. Huang, B. H. Lee, and S. F. Chang. 2006. Integrated human papillomavirus types 52 and 58 are infrequently found in cervical cancer, and high viral loads predict risk of cervical cancer. Gynecol. Oncol. 102:54-60.
18. Hopman, A. H., M. A. Kamps, F. Smedts, E. J. Speel, C. S. Herrington, and F. C. Ramaekers. 2005. HPV in situ hybridization: impact of different protocols on the detection of integrated HPV. Int. J. Cancer 115:419-428.
19. Huang, L. W., S. L. Chao, P. H. Chen, and H. P. Chou. 2004. Multiple HPV genotypes in cervical carcinomas: improved DNA detection and typing in archival tissues. J. Clin. Virol. 29:271-276.
20. Hudelist, G., M. Manavi, K. I. Pischinger, T. Watkins-Riedel, C. F. Singer, E. Kubista, and K. F. Czerwenka. 2004. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol. Oncol. 92:873-880.
21. Jacobs, M. V., P. J. Snijders, A. J. van den Brule, T. J. Helmerhorst, C. J. Meijer, and J. M. Walboomers. 1997. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J. Clin. Microbiol. 35:791-795.
22. Klaes, R., S. M. Woerner, R. Ridder, N. Wentzensen, M. Duerst, A. Schneider, B. Lotz, P. Melsheimer, and M. von Knebel Doeberitz. 1999. Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res. 59:6132-6136.
23. Kong, C. S., B. L. Balzer, M. L. Troxell, B. K. Patterson, and T. A. Longacre. 2007. p16INK4A immunohistochemistry is superior to HPV in situ hybridization for the detection of high-risk HPV in atypical squamous metaplasia. Am. J. Surg. Pathol. 31:33-43.
24. Lin, C. Y., H. C. Chen, R. W. Lin, S. L. You, C. M. You, L. C. Chuang, M. H. Pan, M. H. Lee, Y. C. Chou, and C. J. Chen. 2007. Quality assurance of genotyping array for detection and typing of human papillomavirus. J. Virol. Methods 140:1-9.
25. Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, and C. J. Meijer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
26. Nagai, Y., T. Maehama, T. Asato, and K. Kanazawa. 2000. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: is it an alarm for disease recurrence? Gynecol. Oncol. 79:294-299.
27. Nobbenhuis, M. A., C. J. Meijer, A. J. van den Brule, L. Rozendaal, F. J. Voorhorst, E. K. Risse, R. H. Verheijen, and T. J. Heimerhorst. 2001. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br. J. Cancer 84:796-801.
28. Peitsaro, P., B. Johansson, and S. Syrjanen. 2002. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J. Clin. Microbiol. 40:886-891.
29. Pett, M. R., W. O. Alazawi, I. Roberts, S. Dowen, D. I. Smith, M. A. Stanley, and N. Coleman. 2004. Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res. 64:1359-1368.
30. Pett, M. R., M. T. Herdman, R. D. Palmer, G. S. Yeo, M. K. Shivji, M. A. Stanley, and N. Coleman. 2006. Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. Proc. Natl. Acad. Sci. USA 103:3822-3827.
31. Player, A. N., L. P. Shen, D. Kenny, V. P. Antao, and J. A. Kolberg. 2001. Single-copy gene detection using branched DNA (bDNA) in situ hybridization. J. Histochem. Cytochem. 49:603-612.
32. Plummer, T. B., A. C. Sperry, H. S. Xu, and R. V. Lloyd. 1998. In situ hybridization detection of low copy nucleic acid sequences using catalyzed reporter deposition and its usefulness in clinical human papillomavirus typing. Diagn. Mol. Pathol. 7:76-84.
33. Sano, T., T. Hikino, Y. Niwa, K. Kashiwabara, T. Oyama, T. Fukuda, and T. Nakajima. 1998. In situ hybridization with biotinylated tyramide amplification: detection of human papillomavirus DNA in cervical neoplastic lesions. Mod Pathol. 11:19-23.
34. Unger, E. R., S. D. Vernon, D. R. Lee, D. L. Miller, and W. C. Reeves. 1998. Detection of human papillomavirus in archival tissues: comparison of in situ hybridization and polymerase chain reaction. J. Histochem. Cytochem. 46: 535-540.
35. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Munoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
36. Wright, T. C., Jr., J. T. Cox, L. S. Massad, J. Carlson, L. B. Twiggs, and E. J. Wilkinson. 2003. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am. J. Obstet. Gynecol. 189:295-304.
37. Wright, T. C., Jr., M. Schiffman, D. Solomon, J. T. Cox, F. Garcia, S. Goldie, K. Hatch, K. L. Noller, N. Roach, C. Runowicz, and D. Saslow. 2004. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet. Gynecol. 103:304-309.
38. Yang, B., N. Prescott, J. D. Pettay, R. Arciaga, and R. R. Tubbs. 2006. Evaluation of an automated enhanced sensitivity HPV in situ hybridization assay in cervical and vulvar squamous dysplasia (CIN/VIN), abstr. Modern Pathol. 19:202A.
39. zur Hausen, H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2:342-350.